# Treatment of Epidermoid Cysts

> **NCT05597995** · PHASE2 · UNKNOWN · sponsor: **Goldman, Butterwick, Fitzpatrick and Groff** · enrollment: 10 (estimated)

## Conditions studied

- Epidermoid Cyst

## Interventions

- **DRUG:** Sodium Tetradecyl Sulfate

## Key facts

- **NCT ID:** NCT05597995
- **Lead sponsor:** Goldman, Butterwick, Fitzpatrick and Groff
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-01
- **Primary completion:** 2023-05-30
- **Final completion:** 2023-05-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2022-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05597995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05597995, "Treatment of Epidermoid Cysts". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05597995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*